首页 >
法规速递
-
Page: Pre-authorisation guidance under the Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6)-2025/11/28
2025-12-01查看详情 > -
国家药监局关于修订贝伐珠单抗注射液说明书的公告（2025年第130号） -2025/12/31
2026-01-03查看详情 > -
Page: Fees for veterinary medicines-2026/2/6
2026-02-09查看详情 > -
Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs-2026/3/17
2026-03-18查看详情 > -
国家药品监督管理局 公安部 国家禁毒委员会办公室关于进一步加强普瑞巴林等药品管理的通告（2026年第11号）-2026/4/20
2026-04-21查看详情 > -
Document: Meeting summaries of the Immunisation and Vaccine Monitoring Advisory Board (IVMAB)-2026/6/2
2026-06-02查看详情 > -
Page: Changing the labelling and package leaflet (Article 61(3) notifications)-2026/7/14
2026-07-15查看详情 > -
Scientific guideline: ICH Guideline M13A on bioequivalence for immediate-release solid oral dosage forms - Step 2b-2023/02/07
2023-02-07查看详情 > -
国家药监局 海关总署关于增设泰州市泰州港口岸为药品进口口岸的公告（2023年第110号）-2023/8/31
2023-09-01查看详情 > -
Draft Guidance for Industry: E2D(R1) Post-Approval Safety Data: Definitions and Standards for Management and Reporting of Individual Case Safety Reports-2024/3/13
2024-03-15查看详情 >
